You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic kidney cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

Not yet recruiting
  • Prostate Cancer
  • +11 more
  • Guided physical exercise
  • +2 more
  • Tampere, Länsi-Suomi, Finland
    Tampere University Hospital
Apr 3, 2023

Kidney Tumor Trial in France (blood sampling for ITK dosage)

Recruiting
  • Kidney Neoplasm
  • blood sampling for ITK dosage
  • Marseille, France
  • +4 more
Jan 6, 2023

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Biospecimen Collection
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Assess Safety and Effectiveness of Zirabev in Domestic Various

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +7 more
  • (no location specified)
Jun 30, 2022

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Therapeutic Combination in Advanced or Metastatic Kidney Cancer

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Blood collection
  • Tumour samples
  • Paris, France
  • +1 more
Mar 9, 2022

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Metastatic Renal Cell Carcinoma Trial in Australia, Canada (Ipilimumab/ Nivolumab, SBRT + Ipilimumab/Nivolumab)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab/ Nivolumab
  • SBRT + Ipilimumab/Nivolumab
  • Melbourne, Australia
  • +7 more
Mar 30, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (procedure,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cryosurgery
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 6, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)

Completed
  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • stereotactic body radiation therapy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

Completed
Has Results
  • Kidney Cancer
  • recombinant interferon alfa
  • tretinoin liposome
  • New York, New York
  • +1 more
Mar 17, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute®-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

Survivorship, Prostate Cancer, Kidney Cancer Trial in Cork (Physiotherapy, Dietitian Support, Nursing and Psychosocial)

Recruiting
  • Survivorship
  • +5 more
  • Physiotherapy
  • +2 more
  • Cork, Ireland
    Cork University Hospital
Jul 17, 2023

Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

Completed
Has Results
  • Metastatic Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 8, 2022

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Disease Burden and Biology Using Tumor Cell Free DNA in

Recruiting
  • Renal Cell Carcinoma
  • Blood collection
  • Urine collection
  • Nashville, Tennessee
  • +2 more
Sep 1, 2021

Nivolumab in Recurring Kidney Cancer Participants

Completed
  • Kidney Cancer
  • Renal Cancer
  • Non-Interventional
  • Tokyo, Japan
    Local Institution - 0001
Oct 19, 2022

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023